CARBOGNANI, Paolo
 Distribuzione geografica
Continente #
NA - Nord America 12.994
EU - Europa 11.277
AS - Asia 10.370
SA - Sud America 1.315
AF - Africa 507
Continente sconosciuto - Info sul continente non disponibili 249
OC - Oceania 9
Totale 36.721
Nazione #
US - Stati Uniti d'America 12.667
IT - Italia 5.168
SG - Singapore 3.864
CN - Cina 2.926
VN - Vietnam 1.373
IE - Irlanda 1.176
FI - Finlandia 1.036
BR - Brasile 1.002
SE - Svezia 984
HK - Hong Kong 754
DE - Germania 693
UA - Ucraina 612
FR - Francia 484
NL - Olanda 402
TR - Turchia 401
ZA - Sudafrica 378
BD - Bangladesh 365
GB - Regno Unito 239
CA - Canada 205
IN - India 144
AR - Argentina 116
RU - Federazione Russa 99
MX - Messico 69
IQ - Iraq 68
AT - Austria 59
CO - Colombia 57
BE - Belgio 55
PH - Filippine 54
EC - Ecuador 47
PL - Polonia 46
PK - Pakistan 45
JP - Giappone 42
VE - Venezuela 42
KR - Corea 39
ES - Italia 38
CZ - Repubblica Ceca 34
ID - Indonesia 32
CH - Svizzera 31
UZ - Uzbekistan 30
TH - Thailandia 29
EG - Egitto 25
CI - Costa d'Avorio 24
IR - Iran 23
MA - Marocco 23
SA - Arabia Saudita 22
LT - Lituania 21
JO - Giordania 19
KE - Kenya 19
KZ - Kazakistan 18
AZ - Azerbaigian 16
MY - Malesia 16
TW - Taiwan 16
AE - Emirati Arabi Uniti 15
DK - Danimarca 15
RO - Romania 15
CL - Cile 14
PE - Perù 13
JM - Giamaica 12
UY - Uruguay 12
IL - Israele 11
TN - Tunisia 11
HN - Honduras 9
AU - Australia 8
BG - Bulgaria 8
OM - Oman 8
PY - Paraguay 8
DZ - Algeria 7
GR - Grecia 7
HU - Ungheria 7
NP - Nepal 7
TT - Trinidad e Tobago 7
AL - Albania 6
CR - Costa Rica 6
PA - Panama 6
PT - Portogallo 6
HR - Croazia 5
XK - ???statistics.table.value.countryCode.XK??? 5
AM - Armenia 4
BO - Bolivia 4
EE - Estonia 4
EU - Europa 4
LV - Lettonia 4
MD - Moldavia 4
NG - Nigeria 4
NI - Nicaragua 4
PS - Palestinian Territory 4
BY - Bielorussia 3
ET - Etiopia 3
GE - Georgia 3
GT - Guatemala 3
LA - Repubblica Popolare Democratica del Laos 3
LB - Libano 3
LK - Sri Lanka 3
LU - Lussemburgo 3
RS - Serbia 3
SC - Seychelles 3
SI - Slovenia 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
AO - Angola 2
Totale 36.452
Città #
Singapore 1.933
Chandler 1.357
Ashburn 1.273
San Jose 1.241
Dublin 1.173
Santa Clara 896
Beijing 790
Hong Kong 704
Jacksonville 643
Dallas 472
Dearborn 433
Ho Chi Minh City 413
New York 406
Council Bluffs 381
Boardman 376
Johannesburg 349
Milan 336
Ann Arbor 325
Hanoi 325
Nanjing 323
Izmir 309
Rome 291
Princeton 239
Parma 219
Lauterbourg 218
Los Angeles 203
Shanghai 191
San Mateo 174
Munich 145
Wilmington 125
Toronto 117
Chicago 111
Jinan 111
Helsinki 110
Shenyang 110
Naples 106
Kunming 105
Buffalo 103
Hefei 101
São Paulo 94
Bologna 92
Bremen 92
Nanchang 82
Hebei 81
Columbus 71
Des Moines 70
Seattle 63
Guangzhou 61
Moscow 61
Da Nang 58
Haiphong 56
Turin 56
Tianjin 54
Jiaxing 52
Changsha 51
Brussels 50
Catania 48
Florence 48
Houston 47
Woodbridge 47
London 44
Vienna 44
Bari 43
Kocaeli 40
Palermo 39
Napoli 38
The Dalles 36
Turku 36
Brooklyn 34
Belo Horizonte 32
Chennai 32
Warsaw 32
Orem 31
Düsseldorf 30
Genoa 30
Norwalk 30
Zhengzhou 30
Frankfurt am Main 28
Phoenix 28
Rio de Janeiro 28
Seoul 28
Tokyo 28
Boston 27
Rio Saliceto 27
Augusta 26
Brescia 26
Can Tho 26
Genova 26
Hải Dương 26
Tashkent 26
Falls Church 25
Fremont 25
Modena 25
Nuremberg 25
Abidjan 24
Padova 24
Atlanta 23
Brasília 23
Stockholm 23
Amsterdam 22
Totale 19.761
Nome #
EVOLUZIONE ATIPICA DI UN CASO DI LEIOMIOMA METASTATIZZANTE BENIGNO POLMONARE 2.554
TUMORE FIBROSO SOLITARIO MALIGNO DELLA PLEURA ASSOCIATO A SEVERA IPOGLICEMIA: LA SINDROME DI DOEGE-POTTER 1.934
Diverticolo tracheale acquisito: una rara causa di emottisi 475
LIPOSARCOMA DEDIFERRENZIATO MEDIASTINICO GIGANTE: UN RISCONTRO ESTREMAMENTE RARO 365
LINFOCITI INFILTRANTI IL TUMORE, BAP-1, VEGFR-2 E IGF-1R NEL MESOTELIOMA PLEURICO MALIGNO 270
Polymeric films loaded with cisplatin for malignant pleural mesothelioma: a pharmacokinetic study in an ovine model 253
Hydrogen sulfide inhibits tmprss2 in human airway epithelial cells: Implications for sars‐cov‐2 infection 249
Combined hyaluronate-based films loaded with pemetrexed and cisplatin for the treatment of malignant pleural mesothelioma: Preliminary evaluation in an orthotopic tumor recurrence model 243
Fistola tracheo-esofagea congenita di tipo “H” nell’adulto 229
Changes in pulmonary function test and cardio-pulmonary exercise capacity in COPD patients after lobar pulmonary resection 217
Combined Inhibition of CDK4/6 and PI3K/AKT/mTOR Pathways Induces a Synergistic Anti-Tumor Effect in Malignant Pleural Mesothelioma Cells. 216
Allotrapianto di polmone sinistro nel coniglio.Modello sperimentale per lo studio della conservazione del polmone. 213
Adenocarcinoma associato a melanoma amelanotico primario dell’esofago distale 211
Effect of inducible FHIT and p53 expression in the Calu-1 lung cancer cell line 203
INTEGRATION OF TISSUE PD-1/PD-L1 IMMUNE CHECKPOINT WITH COMPUTED TOMOGRAPHY (CT) BASED TEXTURE ANALYSIS EXHIBITS HIGH PROGNOSTIC IMPACE ON SURGICALLY RESECTED NON SMALL CELL LUNG CANCER (NSCLC) 199
Blood and lymphatic vessels contribute to the impact of the immune microenvironment on clinical outcome in non-small-cell lung cancer 197
Solid-phase microextraction coupled to gas chromatography mass spectrometry followed by multivariate data analysis for the identification of volatile organic compounds as possible biomarkers in lung cancer tissues 195
Surgical treatment of primary and metastatic sternal tumors 194
Early molecular diagnosis of lung cancer: A method to rule out the disease [Diagnosi molecolare precoce del tumore polmonare: Un metodo per escludere Ia malattia] 192
[Experimental tracheal transplantation. Literature review and proposal of an original surgical technique]. 191
Analysis of human breath by SPME-GC/MS: standardization of sample collection using a new device 189
[The transmanubrial approach for tumors of the superior thoracic aperture]. 186
PREDICTIVE AND PROGNOSTIC VALUE OF CLINICAL AND MOLECULAR FEATURES IN PATIENTS UNDERGOING PULMONARY METASTASECTOMY FROM RENAL CELL CARCINOMA 186
Physicochemical and pharmacokinetic properties of polymeric films loaded with cisplatin for the treatment of malignant pleural mesothelioma 185
Leiomioma metastatizzante benigno gigante 184
Pulmonary metastasectomy for colorectal cancer: Analysis of prognostic factors affecting survival 180
Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell lines 179
Left lung allotransplantation in the rabbit. An experimental model for assessment of lung preservation 179
Dose-dependent effect of FHIT-inducible expression in Calu-1 lung cancer cell line 176
Intraoperative Endobronchial swab after major lung resection: does it influence the course of postoperative pulmonary infections ? 175
Intrapleural polymeric devices containing Cisplatin for malignant pleural Mesothelioma in a rat tumor model: a preliminary study. 175
A standard muscle sparing utility thoracotomy for VATS procedures 174
Alpha glucocorticoid receptor expression in different experimental rat models of acute lung injury 174
Biological markers in non-small cell lung cancer. Retrospective study of 10 year follow-up after surgery. 173
[Bronchiolo-alveolar carcinoma. The clinico-diagnostic and therapeutic considerations and the results of a retrospective study in our experience]. 173
An original application of plasma expanders: heart-lung preservation. 172
Lung metastasis resection of adenoid cystic carcinoma of salivary glands 171
CARCINOMA NEUROENDOCRINO PRIMITIVO DEL MEDIASTINO 171
Advantages of multidetector row CT with multiplanar reformation in guiding percutaneous lung biopsies. 170
Cell culture studies of polysaccharide films loaded with cisplatin for the loco-regional therapy of malignant pleural mesothelioma 169
The role of miRNA-221 and miRNA-126 in patients with benign metastasizing leiomyoma of the lung: an overview with new interesting scenarios 168
Neoplasie del polmone in Neoplasie del Distretto Toracico 168
Intrapleural adjuvant treatment of mesothelioma : The combination of cisplatin-pemetrexed in rat tumor model 168
[The use of the pleural tent in superior lobectomies]. 166
Lung mesenchymal cells function as an inductive microenvironment for human lung cancer propagating cells† 166
Linezolid-induced black hairy tongue 165
[Video-assisted major pulmonary resections (lobectomies)]. 164
Exhaled breath analysis in suspected cases of non-small-cell lung cancer: a cross-sectional study 164
Prognostic factors of lung cancer in lymphoma survivors (the LuCiLyS study) 164
) Duplication cystique duodénale: methode originale de traitement endoscopique. 163
Methodology for the assessment of lung protection. Human pulmonary artery endothelial cell preservation using haemaccel. 163
Isolation and characterization of human lung lymphatic endothelial cells 163
Cardiac autonomic and cortisol stress responses to real operations in surgeons: relationship with individual psychobiological characteristics and experience 162
IASLC and WHO 2004 Grading System as Prognostic Factors in 492 Cases of Pulmonary Adenocarcinoma 162
Prognostic value of [18F]FDG PET/CT parameters in surgically resected primary lung adenocarcinoma: a single-center experience 161
Exhaled volatile organic compounds in patients with non-small cell lung cancer: cross sectional and nested short-term follow-up study. 159
Structural and Functional Characterization of the Hemolymphangiogenic Microenvironment in Lung Cancer 159
Spatial architecture of tumour-infiltrating lymphocytes as a prognostic parameter in resected non-small-cell lung cancer 159
Retrospective immunophenotypical evaluation of MET, PD-1/PD-L1, and mTOR pathways in primary tumors and pulmonary metastases of renal cell carcinoma: the RIVELATOR study addresses the issue of biomarkers heterogeneity 157
Lipoma endobronchiale: una rara causa di ostruzione bronchiale 157
Mediastinoscopy, thoracoscopy and left anterior mediastinotomy in the diagnosis of N2 non small cell lung cancer. 156
MEDIASTINITE FIBROSANTE ASSOCIATA A GRNULOMATOSI DI WEGENER 155
An effective solution for prolonged preservation of cultured human pulmonary artery endothelial cells 154
Multiple primary malignancies involving lung cancer: a single-center experience 154
A case of Solitary fibrous pleura tumor associated with severe hypoglycemia: the Doege-Potter 's Syndrome 153
Experimental tracheal transplantation using a cryopreserved aortic allograft 152
INTRAPLEURAL POLYMERIC FILMS CONTAINING CISPLATIN FOR MALIGNANT PLEURAL MESOTHELIOMA: PRELIMINARY PHARMACOKINETIC DATA IN AN OVINE MODEL 152
Conversion due to vascular injury during video-assisted thoracic surgery lobectomy: A multicentre retrospective analysis from the Italian video-assisted thoracic surgery group registry 151
Identification and tumorigenic role of Mesenchymal Stem Cells from human lung cancer 151
Predictive factors of diagnostic accuracy of CT-guided transthoracic fine-needle aspiration for solid noncalcified, subsolid and mixed pulmonary nodules. 151
Determination of aldehydes in exhaled breath of patients with lung cancer by means of on-fiber-derivatization SPME-GC/MS 150
A new extracellular type solution for lung preservation: "in vitro" comparison with Beltzer, low potassium Dextran and Euro-Collins solutions by means of human lung fibroblasts. 150
A novel method of tracheoesophageal fistula closure 150
Immune context characterization and heterogeneity in primary tumors and pulmonary metastases from renal cell carcinoma 150
ANALYSIS OF MICRORNA EXPRESSION IN MALIGNANT PLEURAL MESOTHELIOMA, ASBESTOSIS AND BENIGN PULMONARY DISEASE: A PRELIMINARY STUDY 147
Adjuvant chemotherapy for large-cell neuroendocrine lung carcinoma: Results from the European Society for Thoracic Surgeons Lung Neuroendocrine Tumours Retrospective Database 147
Coordinated inducible expression of p53 and FHIT has a strong anti proliferative effect in Calu-1 lung cancer cell line. 146
Grading the neuroendocrine tumors of the lung: an evidence-based proposal. 146
Anti-proliferative effect of induced Fhit expression in non small cell lung cancer cell line (Calu-1) 146
A huge ulcerated mass of the thorax 145
The Overweight Paradox: Impact of Body Mass Index on Patients Undergoing VATS Lobectomy or Segmentectomy 144
Alpha glucocorticoid receptor expression in different experimental models of lung injury 144
Biological variables in non-small cell lung cancer: comparison between immunocytochemical determination on fine needle aspirates from surgical specimens and immunohistochemical determination on tissue sections 143
Exercise capacity assessment in patients undergoing lung resection 143
Relationship Between the Diffusing Capacity of the Lung for Carbon Monoxide (DLCO) and Lung Adenocarcinoma Patterns: New Possible Insights 142
) Ultrastructural damage of the pulmonary endothelial cell after storage in lung preservation solutions. Comparison between Belzer and Euro-Collins solutions. 141
Longitudinal evolution of incidentally detected solitary pure ground-glass nodules on ct: Relation to clinical metrics 141
Long-lasting tuberculous pleurisy 141
Abdominal visceral hernia through a chest wall defect secondary to open-window thoracostomy 141
microRNAs Expression in Malignant Pleural Mesothelioma, Asbestosis and Benign Pulmonary Disease 141
The value of lung metastases resection from adenoid cystic carcinoma 140
CT-guided transthoracic needle biopsy in the diagnosis of chest tumours. 140
Electromyographic evaluation of the spared serratus anterior after postero-lateral thoracotomy. 139
Plasma and EBC microRNAs as early biomarkers of non-small-cell lung cancer 139
EXCEPTIONAL EVOLUTION OF BENIGN METASTASIZING LEIOMYOMAS OF THE LUNG 139
Pneumocytes type II ultrastructural modifications after storage in preservation solutions for transplantation. 138
Ground glass nodules evolution according with an history of tumour 138
YKL-40 and mesothelin in the blood of patients with malignant mesothelioma, lung cancer and asbestosis. 136
Giant intercostal nerve schwannoma in a patient with neurofibromatosis type 2 136
Differential Tumorigenic Properties of Mesenchymal Cells From Neoplastic and Non-Neoplastic Human Lung in NSCLC 136
Totale 21.407
Categoria #
all - tutte 117.262
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 117.262


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.293 0 0 55 67 51 37 176 180 86 115 87 439
2022/20235.161 472 553 308 389 451 605 103 357 1.547 52 234 90
2023/20242.300 158 225 86 72 168 537 135 171 100 124 190 334
2024/20255.767 165 326 393 310 576 647 206 245 801 541 511 1.046
2025/202611.790 1.088 937 1.313 963 1.680 670 1.326 439 1.561 848 526 439
2026/20271.261 268 634 359 0 0 0 0 0 0 0 0 0
Totale 36.721